[go: up one dir, main page]

Sheibani et al., 1995 - Google Patents

Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis.

Sheibani et al., 1995

View PDF
Document ID
6188106245003835983
Author
Sheibani N
Frazier W
Publication year
Publication venue
Proceedings of the National Academy of Sciences

External Links

Snippet

Murine endothelial cells are readily transformed in a single step by the polyomavirus oncogene encoding middle-sized tumor antigen. These cells (bEND. 3) form tumors (hemangiomas) in mice which are lethal in newborn animals. The bEND. 3 cells rapidly …
Continue reading at www.pnas.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells

Similar Documents

Publication Publication Date Title
Sheibani et al. Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis.
Schor et al. Tumour angiogenesis
Weinstat-Saslow et al. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis
Madri et al. Angiogenesis
Montesano et al. In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices.
Wikner et al. Transforming growth factor-β stimulates the expression of fibronectin by human keratinocytes
Nör et al. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression
Carmeliet et al. Transgenic mouse models in angiogenesis and cardiovascular disease
Karsan et al. Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms
Desmoulière et al. The role of the myofibroblast in wound healing and fibrocontractive diseases
Sato et al. Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells
Montesano et al. Tumor-promoting phorbol esters induce angiogenesis in vitro
Shih et al. The role of E-cadherin in the motility and invasion of implantation site intermediate trophoblast
Attur et al. Functional genomic analysis in arthritis-affected cartilage: yin-yang regulation of inflammatory mediators by α5β1 and αVβ3 integrins
Jahroudi et al. The role of endothelial cells in tumor invasion and metastasis
Schlumberger et al. Collagen synthesis in cultured aortic smooth muscle cells. Modulation by collagen lattice culture, transforming growth factor-beta 1, and epidermal growth factor.
IL112766A (en) Pharmaceutical compositions containing oncostatin m for enhancing fibrinolysis and thrombolysis
US6498144B1 (en) Use of scatter factor to enhance angiogenesis
Petrides et al. How do normal and leukemic white blood cells egress from the bone marrow? Morphological facts and biochemical riddles
Blaschuk et al. Myoblast αvβ3 integrin levels are controlled by transcriptional regulation of expression of the β3 subunit and down-regulation of β3 subunit expression is required for skeletal muscle cell differentiation
KR20010022887A (en) Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity
WO1994004190A1 (en) Regulation of cellular invasiveness
Thamm et al. Biological and molecular characterization of a canine hemangiosarcoma-derived cell line
Vadas et al. Regulation of eosinophil function by P-selectin
US5202116A (en) Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m